Gast ::
| Hauptseite > Publikationsdatenbank > Comment on “Hypometabolic gliomas on FET-PET - Is there an inverted U-curve for survival?”, Kamson 2019, Neuro-Oncology > print |
| Hauptseite > Publikationsdatenbank > Comment on “Hypometabolic gliomas on FET-PET - Is there an inverted U-curve for survival?”, Kamson 2019, Neuro-Oncology > print |
| 001 | 865194 | ||
| 005 | 20210130002937.0 | ||
| 024 | 7 | _ | |a 10.1093/neuonc/noz173 |2 doi |
| 024 | 7 | _ | |a 1522-8517 |2 ISSN |
| 024 | 7 | _ | |a 1523-5866 |2 ISSN |
| 024 | 7 | _ | |a altmetric:66465519 |2 altmetric |
| 024 | 7 | _ | |a pmid:31504819 |2 pmid |
| 024 | 7 | _ | |a WOS:000509393300018 |2 WOS |
| 037 | _ | _ | |a FZJ-2019-04730 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Galldiks, Norbert |0 P:(DE-Juel1)143792 |b 0 |e Corresponding author |u fzj |
| 245 | _ | _ | |a Comment on “Hypometabolic gliomas on FET-PET - Is there an inverted U-curve for survival?”, Kamson 2019, Neuro-Oncology |
| 260 | _ | _ | |a Oxford |c 2019 |b Oxford Univ. Press |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1576649499_5126 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a With great interest we read the editorial by Kamson entitled “Hypometabolic Gliomas on FET-PET—Is There an Inverted U-Curve for Survival?” in Neuro-Oncology1 referring to our publication regarding the clinical relevance of photopenic defects on O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET in glioma patients.2 In that paper, we identified within 100 patients with FET-PET–negative gliomas a subgroup of patients who even exhibit photopenic defects and had, moreover, an unfavorable outcome compared with gliomas with indifferent FET uptake (isometabolic gliomas). From our point of view, the frequency of photopenic defects is even lower than 10% (ie, ~5%). In his editorial, the author raised valuable new thoughts and ideas that are worth discussing. |
| 536 | _ | _ | |a 572 - (Dys-)function and Plasticity (POF3-572) |0 G:(DE-HGF)POF3-572 |c POF3-572 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef |
| 700 | 1 | _ | |a Verger, Antoine |0 P:(DE-Juel1)171957 |b 1 |
| 700 | 1 | _ | |a Zaragori, Timothée |0 P:(DE-HGF)0 |b 2 |
| 700 | 1 | _ | |a Unterrainer, Marcus |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Suchorska, Bogdana |0 P:(DE-HGF)0 |b 4 |
| 700 | 1 | _ | |a Lohman, Philipp |0 P:(DE-HGF)0 |b 5 |
| 700 | 1 | _ | |a Tonn, Jörg C |0 P:(DE-HGF)0 |b 6 |
| 700 | 1 | _ | |a Langen, Karl-Josef |0 P:(DE-Juel1)131777 |b 7 |u fzj |
| 700 | 1 | _ | |a Albert, Nathalie L |0 P:(DE-HGF)0 |b 8 |
| 773 | _ | _ | |a 10.1093/neuonc/noz173 |g p. noz173 |0 PERI:(DE-600)2094060-9 |n 12 |p 1612-1613 |t Neuro-Oncology |v 21 |y 2019 |x 1523-5866 |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/865194/files/noz173.pdf |y Restricted |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/865194/files/noz173.pdf?subformat=pdfa |x pdfa |y Restricted |
| 909 | C | O | |o oai:juser.fz-juelich.de:865194 |p VDB |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 0 |6 P:(DE-Juel1)143792 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 5 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a INM-4 |0 I:(DE-HGF)0 |b 5 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 7 |6 P:(DE-Juel1)131777 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |l Decoding the Human Brain |1 G:(DE-HGF)POF3-570 |0 G:(DE-HGF)POF3-572 |2 G:(DE-HGF)POF3-500 |v (Dys-)function and Plasticity |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |
| 914 | 1 | _ | |y 2019 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NEURO-ONCOLOGY : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b NEURO-ONCOLOGY : 2017 |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-3-20090406 |k INM-3 |l Kognitive Neurowissenschaften |x 0 |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-4-20090406 |k INM-4 |l Physik der Medizinischen Bildgebung |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-Juel1)INM-3-20090406 |
| 980 | _ | _ | |a I:(DE-Juel1)INM-4-20090406 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|